Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
The EMBO Journal
|
March 1, 1987
Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line
C M Chang, K S Jeng, C P Hu, et al.
Genomics
|
July 24, 1998
Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma
A P Tsou, K M Wu, T Y Tsen, et al.
Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi = Chinese Journal of Microbiology and Immunology
|
August 1, 1987
Monoclonal antibodies against human esophageal carcinoma cell lines
H G Hsieh, C P Hu, S H Han, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1986
Monoclonal antibodies against antigens expressed on human hepatocellular carcinoma cells
C P Hu, S H Han, W Y Lui, et al.
Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi = Chinese Journal of Microbiology and Immunology
|
August 1, 1982
[A new human hepatoma cell line: establishment and characterization]
Y M Lin, C P Hu, C K Chou, et al.
Gene Therapy
|
May 13, 2011
Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus
C-C Chen, C-M Chang, C-P Sun, et al.
Zhonghua Yi Xue Za Zhi
|
March 12, 2020
[Construction and evaluation of a novel diagnosis pathway for 2019-Corona Virus Disease]
Z Xiong, L Fu, H Zhou, et al.
Gene Therapy
|
August 25, 2006
Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA
C-C Chen, T-M Ko, H-I Ma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 8, 2016
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials
J C-H Yang, L V Sequist, C Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2013
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)
G Chen, J Feng, C Zhou, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
The EMBO Journal
|
March 1, 1987
Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line
C M Chang, K S Jeng, C P Hu, et al.
Genomics
|
July 24, 1998
Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma
A P Tsou, K M Wu, T Y Tsen, et al.
Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi = Chinese Journal of Microbiology and Immunology
|
August 1, 1987
Monoclonal antibodies against human esophageal carcinoma cell lines
H G Hsieh, C P Hu, S H Han, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1986
Monoclonal antibodies against antigens expressed on human hepatocellular carcinoma cells
C P Hu, S H Han, W Y Lui, et al.
Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi = Chinese Journal of Microbiology and Immunology
|
August 1, 1982
[A new human hepatoma cell line: establishment and characterization]
Y M Lin, C P Hu, C K Chou, et al.
Gene Therapy
|
May 13, 2011
Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus
C-C Chen, C-M Chang, C-P Sun, et al.
Zhonghua Yi Xue Za Zhi
|
March 12, 2020
[Construction and evaluation of a novel diagnosis pathway for 2019-Corona Virus Disease]
Z Xiong, L Fu, H Zhou, et al.
Gene Therapy
|
August 25, 2006
Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA
C-C Chen, T-M Ko, H-I Ma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 8, 2016
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials
J C-H Yang, L V Sequist, C Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2013
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)
G Chen, J Feng, C Zhou, et al.
Page
of 10